ISPOR
ISPOR[edit | edit source]
ISPOR, the International Society for Pharmacoeconomics and Outcomes Research, is a professional organization dedicated to the advancement of health economics and outcomes research (HEOR) globally. It provides a platform for the exchange of knowledge and information among researchers, healthcare practitioners, decision-makers, and other stakeholders in the healthcare industry.
History[edit | edit source]
ISPOR was founded in 1995 with the mission to promote the science of pharmacoeconomics and outcomes research. Over the years, it has grown to become a leading global organization in the field, with members from over 120 countries.
Mission and Goals[edit | edit source]
The mission of ISPOR is to promote health economics and outcomes research excellence to improve decision making for health globally. Its goals include:
- Advancing the science of HEOR
- Providing education and training
- Facilitating the translation of HEOR into practice
- Promoting the use of HEOR in healthcare decision making
Activities[edit | edit source]
ISPOR organizes a variety of activities to achieve its mission, including:
Conferences[edit | edit source]
ISPOR hosts annual conferences that bring together experts from around the world to discuss the latest research and developments in HEOR. These conferences provide opportunities for networking, collaboration, and professional development.
Publications[edit | edit source]
ISPOR publishes several journals, including Value in Health and Value in Health Regional Issues, which feature peer-reviewed articles on topics related to health economics and outcomes research.
Educational Programs[edit | edit source]
The organization offers educational programs, workshops, and webinars to provide training and development opportunities for professionals in the field.
Membership[edit | edit source]
ISPOR membership is open to individuals and organizations interested in health economics and outcomes research. Members benefit from access to a global network of professionals, resources, and opportunities for professional growth.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
